Home
About
FAQ
History (15)
Reducing Mobility Loss by Increasing Access to a Community-Based Walking Program (Walk On!) For Older Adults with Functional Limitations.
Environmental enrichment and abstinence attenuate ketamine-induced cardiac and renal toxicity.
Using Time-Varying Caloric Vestibular Stimulation to Improve Neurovascular Status in Parkinson's Disease
Lung Structure and Risk of Sleep Apnea in SPIROMICS.
Variation of ictal electroencephalographic regularity with low-, moderate-, and high-dose stimuli during right unilateral electroconvulsive therapy.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (16)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Christopher M. Peters PhD
Wake Forest School of Medicine
Why?
James C. Eisenach MD
Wake Forest School of Medicine
Why?
Debra I. Diz PhD
Wake Forest School of Medicine
Why?
Edgar A. Romero-Sandoval MD, PhD
Wake Forest School of Medicine
Why?
Liliya M. Yamaleyeva MD, MS, FAHA
Wake Forest School of Medicine
Why?
Janus Kumar S. Patel MD, MPH
Wake Forest School of Medicine
Why?
Elisabeth A. Tallant PhD
Wake Forest School of Medicine
Why?
Stephen Peters MD, PhD
Wake Forest School of Medicine
Why?
Roy E. Strowd MD, MEd, MS
Wake Forest School of Medicine
Why?
Mark C. Chappell PhD
Wake Forest School of Medicine
Why?
Chuanyao Tong MD
Wake Forest School of Medicine
Why?
Stephen Kritchevsky PhD
Wake Forest School of Medicine
Why?
Mary E. Pylipow
Why?
Allyn Howlett PhD
Wake Forest School of Medicine
Why?
Mark A. Espeland PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 2
Next
Prev
Search Criteria
Prostaglandins
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions